Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
GlaxoSmithKline
Alexion Pharmaceuticals, Inc.
The Cleveland Clinic
Peking University People's Hospital
Peking University People's Hospital
Massachusetts General Hospital
Brigham and Women's Hospital
Fondazione IRCCS Policlinico San Matteo di Pavia
Weill Medical College of Cornell University
Kedrion S.p.A.
Universitaire Ziekenhuizen KU Leuven
University of Texas Southwestern Medical Center
City of Hope Medical Center
Mayo Clinic
Peking University People's Hospital
Memorial Sloan Kettering Cancer Center
Boston Medical Center
Life Molecular Imaging SA
Columbia University
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
European Myeloma Network B.V.
SWOG Cancer Research Network
European Myeloma Network B.V.
Attralus, Inc.
University Hospital, Essen
Tufts Medical Center
Beijing Anzhen Hospital
Peking Union Medical College Hospital
University Hospital, Angers
Nexcella Inc.
Nanjing IASO Biotechnology Co., Ltd.
Barbara Ann Karmanos Cancer Institute
Columbia University
UNC Lineberger Comprehensive Cancer Center
Sanofi
Peking Union Medical College Hospital
Beijing Boren Hospital
Hadassah Medical Organization
Fondazione IRCCS Policlinico San Matteo di Pavia
Peking University People's Hospital
Leiden University Medical Center
Alexion Pharmaceuticals, Inc.
St. Olavs Hospital
Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia